In fact, the transition from hepatocellular carcinoma tumor initiation to its proliferation has been effectively suppressed by epigallocatechin-gallate through downregulation of expression levels of p53, NFκB, EGFR, cyclins, and upregulation of BAX [110]. The gene discussed is TP53; the disease is hepatocellular carcinoma.